|Bid||6.50 x N/A|
|Ask||8.95 x N/A|
|Day's Range||7.33 - 8.20|
|52 Week Range||4.00 - 11.34|
|Beta (5Y Monthly)||1.68|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
HOUSTON and VANCOUVER, BC, Nov. 25, 2020 /CNW/ - ESSA Pharma Inc.
Alzheimer Society of Canada calls for increased investment into groundbreaking research TORONTO, Nov. 10, 2020 /CNW/ - The Alzheimer Society of Canada is disappointed to hear that, after reviewing data from Phase 3 clinical trials, a U.
HOUSTON and VANCOUVER, BC, Oct. 26, 2020 /CNW/ - ESSA Pharma Inc.